J. Horwitz

发表

HIV therapy by a combination of broadly neutralizing antibodies in humanized mice

Ron Diskin, Michael S. Seaman, Florian Klein, 2012, Nature.

Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo

A. Chakraborty, M. Nussenzweig, A. Gazumyan, 2016, Science.

Enhanced clearance of HIV-1-infected cells by anti-HIV-1 broadly neutralizing antibodies in vivo

A. Chakraborty, M. Nussenzweig, A. Gazumyan, 2016 .

Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice

C. Rice, L. Chiriboga, C. Walker, 2015, Hepatology.

Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.

C. Rice, Rachael N. Labitt, M. Dorner, 2013, Virology.

3BNC117 a Broadly Neutralizing Antibody Suppresses Viremia in HIV-1-Infected Humans

B. Walker, M. Nussenzweig, R. Gorelick, 2016 .

Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice

C. Rice, Rachael N. Labitt, A. Ploss, 2013, The Journal of Immunology.

MiceHLA-Transgenic Human Immune System Hepatotropic Virus Infection in Adaptive Immune Responses during Characterization of Human Antiviral

C. Rice, Rachael N. Labitt, A. Ploss, 2013 .

Structure of a rabies virus polymerase complex from electron cryo-microscopy

S. Harrison, S. Whelan, S. Jenni, 2019, Proceedings of the National Academy of Sciences.

HIV-1 Vpu restricts Fc-mediated effector functions in vivo

B. Haynes, S. Zolla-Pazner, D. Burton, 2022, bioRxiv.

Expanding the Host Range of Hepatitis C Virus through Viral Adaptation

C. Rice, T. Pietschmann, Sherif Gerges, 2016, mBio.

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

Michael S. Seaman, Florian Klein, Anthony P. West, 2015, Nature.

Visualizing molecular interactions that determine assembly of a bullet-shaped vesicular stomatitis virus particle

S. Harrison, S. Whelan, Louis-Marie Bloyet, 2022, Nature Communications.

A genetically humanized mouse model for hepatitis C virus infection

Charles M. Rice, Dennis R. Burton, Christopher T. Jones, 2011, Nature.

Completion of the entire hepatitis C virus life-cycle in genetically humanized mice

Charles M. Rice, Shizuo Akira, Taro Kawai, 2013, Nature.

Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo

S. Zolla-Pazner, M. Nussenzweig, D. Fera, 2017, Cell.

Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller

B. Walker, D. Burton, Stuart A. Sievers, 2017, Science Translational Medicine.

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

Nico Pfeifer, Michael S. Seaman, Florian Klein, 2016, Nature.

Computational analysis of anti–HIV-1 antibody neutralization panel data to identify potential functional epitope residues

Florian Klein, Michel C Nussenzweig, M. Nussenzweig, 2013, Proceedings of the National Academy of Sciences.

A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo

B. Walker, John P. Moore, Stuart A. Sievers, 2015, PLoS pathogens.

Brief Definitive Report

S. Zolla-Pazner, M. Nussenzweig, A. West, 2022 .

Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice

M. Nussenzweig, A. Tarakhovsky, R. Prinjha, 2014, Cell.

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice

Rolf Kaiser, Florian Klein, Michel C Nussenzweig, 2013, Proceedings of the National Academy of Sciences.

Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies

Ron Diskin, Michael S. Seaman, Florian Klein, 2013, The Journal of experimental medicine.

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA

A. Chakraborty, G. Learn, M. Nussenzweig, 2016, Proceedings of the National Academy of Sciences.

Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission

M. Nussenzweig, H. Mouquet, O. Schwartz, 2013, The Journal of experimental medicine.

Biological performance of biodegradable amino acid-based poly(ester amide)s: Endothelial cell adhesion and inflammation in vitro.

Josephine C Bodle, Cynthia A Reinhart-King, Chih-Chang Chu, 2010, Journal of biomedical materials research. Part A.

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

B. Walker, M. Nussenzweig, A. West, 2015, Nature.

Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.

C. Rice, Rachael N. Labitt, M. Dorner, 2013, Virology.

Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein.

C. Rice, M. Dorner, Tamar Friling, 2013, Virology.

Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants

Thomas R. Eisenreich, A. Gazumyan, M. Seaman, 2014, The Journal of experimental medicine.

Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants

Thomas R. Eisenreich, A. Gazumyan, M. Seaman, 2014 .